End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 NZD | -2.36% | -3.33% | -17.14% |
May. 01 | AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV | MT |
Apr. 24 | New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.14% | 183M | |
+33.43% | 700B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+15.55% | 236B | |
+6.60% | 202B | |
-9.28% | 197B | |
+4.26% | 161B | |
-3.54% | 157B |
- Stock Market
- Equities
- AFT Stock
- News AFT Pharmaceuticals Limited
- AFT Pharmaceuticals’ Maxigesic IV Launches in the US